002294.SZ
Shenzhen Salubris Pharmaceuticals Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 31.62
−3.24%Margins
Gross margin
75.1%
EBITDA margin
24.5%
EBIT margin
15.7%
Net margin
15.0%
FCF margin
0.7%
7.4%
Return on equity
5.9%
Return on assets
7.6%
Return on invested capital
0.40x
Asset turnover
CNY 1.1B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026